stocks logo

ACB

Aurora Cannabis Inc
$
4.810
-0.07(-1.434%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.9287
Open
4.850
VWAP
4.86
Vol
527.44K
Mkt Cap
270.55M
Low
4.800
Amount
2.56M
EV/EBITDA(TTM)
--
Total Shares
54.55M
EV
380.44M
EV/OCF(TTM)
20.90
P/S(TTM)
1.05
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
70.00M
+8.66%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Aurora Cannabis Inc. (ACB) for FY2026, with the revenue forecasts being adjusted by -2.31% over the past three months. During the same period, the stock price has changed by 0.00%.
Revenue Estimates for FY2026
Revise Downward
down Image
-2.31%
In Past 3 Month
Stock Price
No Change
down Image
0.00%
In Past 3 Month
1 Analyst Rating
up Image
6.86% Upside
Wall Street analysts forecast ACB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACB is 5.14 USD with a low forecast of 5.14 USD and a high forecast of 5.14  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
up Image
6.86% Upside
Current: 4.810
sliders
Low
5.14
Averages
5.14
High
5.14
No Data

Valuation Metrics

The current forward P/E ratio for Aurora Cannabis Inc (ACB.O) is 41.49, compared to its 5-year average forward P/E of -53.82. For a more detailed relative valuation and DCF analysis to assess Aurora Cannabis Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-53.82
Current PE
41.49
Overvalued PE
299.49
Undervalued PE
-407.13

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-96.26
Current EV/EBITDA
6.87
Overvalued EV/EBITDA
289.27
Undervalued EV/EBITDA
-481.79

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.31
Current PS
1.05
Overvalued PS
6.12
Undervalued PS
0.50

Financials

Annual
Quarterly
FY2025Q4
YoY :
+34.31%
90.54M
Total Revenue
FY2025Q4
YoY :
+4.98%
-44.07M
Operating Profit
FY2025Q4
YoY :
+8.47%
-21.98M
Net Income after Tax
FY2025Q4
YoY :
+4.88%
-0.43
EPS - Diluted
FY2025Q4
YoY :
-98.88%
-286.00K
Free Cash Flow
FY2025Q4
YoY :
-56.06%
0.29
Gross Profit Margin - %
FY2025Q4
YoY :
-99.36%
-0.19
FCF Margin - %
FY2025Q4
YoY :
-19.23%
-24.28
Net Margin - %
FY2025Q4
1.24
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
6.1K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

ACB News & Events

Events Timeline

2025-06-25 (ET)
2025-06-25
13:49:12
U.S. House okays amendment on VA cannabis recommendations, Marijuana Herald says
select
2025-06-24 (ET)
2025-06-24
07:04:01
Aurora Cannabis launches two new proprietary cultivars in Poland
select
2025-06-19 (ET)
2025-06-19
07:47:17
Aurora Cannabis says 'second instance of misinformation' posted on Investing.com
select
Sign Up For More Events

News

1.0
07-23Newsfilter
Aurora Cannabis to Host First Quarter 2026 Investor Conference Call
3.5
07-20Yahoo Finance
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
7.5
07-16PRnewswire
Aurora Continues Deep Commitment to Veterans Through Strains for Heroes Initiative
Sign Up For More News

FAQ

arrow icon

What is Aurora Cannabis Inc (ACB) stock price today?

The current price of ACB is 4.81 USD — it has decreased -1.43 % in the last trading day.

arrow icon

What is Aurora Cannabis Inc (ACB)'s business?

arrow icon

What is the price predicton of ACB Stock?

arrow icon

What is Aurora Cannabis Inc (ACB)'s revenue for the last quarter?

arrow icon

What is Aurora Cannabis Inc (ACB)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Aurora Cannabis Inc (ACB)'s fundamentals?

arrow icon

How many employees does Aurora Cannabis Inc (ACB). have?

arrow icon

What is Aurora Cannabis Inc (ACB) market cap?